<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6</volume><submitter>Wang W</submitter><pubmed_abstract>Bicuspid aortic valve (BAV) is the most common congenital heart disease. The current study aims to construct a diagnostic model based on metabolic profiling as a non-invasive tool for BAV screening. Blood serum samples were prepared from an estimation group and a validation group, each consisting of 30 BAV patients and 20 healthy individuals, and analyzed by liquid chromatography-mass spectrometry (LC-MS). In total, 2213 metabolites were detected and 41 were considered different. A model for predicting BAV in the estimation group was constructed using the concentration levels of monoglyceride (MG) (18:2) and glycerophospho-N-oleoyl ethanolamine (GNOE). A novel model named Zhongshan (ZS) was developed to amplify the association between BAV and the two metabolites. The area under curve (AUC)</pubmed_abstract><journal>Scientific reports</journal><pagination>37023</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5109472</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Analysis of Serum Metabolites to Diagnose Bicuspid Aortic Valve.</pubmed_title><pmcid>PMC5109472</pmcid><pubmed_authors>Kong B</pubmed_authors><pubmed_authors>Xia L</pubmed_authors><pubmed_authors>Liu M</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Tao H</pubmed_authors><pubmed_authors>Wang W</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Maimaiti A</pubmed_authors><pubmed_authors>Zhao Y</pubmed_authors><pubmed_authors>Wei L</pubmed_authors><pubmed_authors>Nian H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Analysis of Serum Metabolites to Diagnose Bicuspid Aortic Valve.</name><description>Bicuspid aortic valve (BAV) is the most common congenital heart disease. The current study aims to construct a diagnostic model based on metabolic profiling as a non-invasive tool for BAV screening. Blood serum samples were prepared from an estimation group and a validation group, each consisting of 30 BAV patients and 20 healthy individuals, and analyzed by liquid chromatography-mass spectrometry (LC-MS). In total, 2213 metabolites were detected and 41 were considered different. A model for predicting BAV in the estimation group was constructed using the concentration levels of monoglyceride (MG) (18:2) and glycerophospho-N-oleoyl ethanolamine (GNOE). A novel model named Zhongshan (ZS) was developed to amplify the association between BAV and the two metabolites. The area under curve (AUC)</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Nov</publication><modification>2026-04-30T01:30:15.927Z</modification><creation>2019-03-27T02:28:59Z</creation></dates><accession>S-EPMC5109472</accession><cross_references><pubmed>27845433</pubmed><doi>10.1038/srep37023</doi></cross_references></HashMap>